We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$685M
AUM Growth
+$52.8M
Cap. Flow
-$4.48M
Cap. Flow %
-0.65%
Top 10 Hldgs %
76.51%
Holding
68
New
1
Increased
7
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
KMI icon
Kinder Morgan
KMI
+$2.37M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.76M
3
MRK icon
Merck
MRK
+$1.01M
4
ABBV icon
AbbVie
ABBV
+$863K
5
ELAN icon
Elanco Animal Health
ELAN
+$418K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.61%
2 Healthcare 34.49%
3 Communication Services 5.12%
4 Energy 4.72%
5 Technology 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVNS
51
DELISTED
Avanos Medical
AVNS
$267K 0.04%
7,911
-577
-7% -$20.9K
MDY icon
52
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$244K 0.04%
651
TLRA
53
DELISTED
Telaria, Inc.
TLRA
$225K 0.03%
25,523
IDXX icon
54
Idexx Laboratories
IDXX
$46.2B
$157K 0.02%
600
NKE icon
55
Nike
NKE
$61.3B
$142K 0.02%
1,400
PEP icon
56
PepsiCo
PEP
$189B
$137K 0.02%
1,000
TRGP icon
57
Targa Resources
TRGP
$56.9B
$127K 0.02%
3,100
HSY icon
58
Hershey
HSY
$36.6B
$88K 0.01%
600
BMY.RT
59
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$84K 0.01%
+28,000
New +$72.8K
NSC icon
60
Norfolk Southern
NSC
$75.2B
$39K 0.01%
200
TR icon
61
Tootsie Roll Industries
TR
$2.97B
$37K 0.01%
1,318
ED icon
62
Consolidated Edison
ED
$39.8B
$23K ﹤0.01%
253
ENB icon
63
Enbridge
ENB
$113B
-9,648
Closed -$338K
GE icon
64
GE Aerospace
GE
$382B
-40,127
Closed -$1.79M
BPL
65
DELISTED
Buckeye Partners, L.P.
BPL
-9,612
Closed -$395K
CTWS
66
DELISTED
Connecticut Water Service Inc
CTWS
-4,000
Closed -$280K
CELG
67
DELISTED
Celgene Corp
CELG
-28,000
Closed -$2.78M

Similar funds

Blackhill Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Blackhill Capital held 68 positions worth $685M, up 8.3% from $633M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Blackhill Capital's Q4 2019 filing shows 1 new, 7 increased, 18 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K. The largest sale was Celgene Corp, an estimated $2.78M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, down from 44% a quarter earlier, followed by Healthcare and Communication Services.

  • Blackhill Capital's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 28,000 shares worth $84K.
  • Blackhill Capital added most to Kinder Morgan in Q4 2019, an estimated $2.37M increase.
  • Blackhill Capital's biggest Q4 2019 reduction was Williams-Sonoma, cutting an estimated $2.61M.
  • Blackhill Capital fully exited Celgene Corp in Q4 2019, selling an estimated $2.78M.
  • Blackhill Capital's ten largest holdings make up 77% of its $685M portfolio in Q4 2019.
  • Blackhill Capital opened 1 new position and closed 5 in Q4 2019.
  • Blackhill Capital's portfolio value rose 8.3% quarter-over-quarter to $685M.

Based on Blackhill Capital's 13F filing for Q4 2019, filed 10 Feb 2020.